Literature DB >> 525291

Racemose haemangioma of the retina. Report of three cases with long term follow-up.

P Bernth-Petersen.   

Abstract

Racemose haegiomas of the retina are rare developmental anomalies. The basic lesion is an abnormal arterio-venous communication. Three new cases with long term follow-up are presented. In two of the cases the first symptom was loss of vision due to retinal and vitreous haemorrhage. In the third case gradual reduction of vision was due to vascular leakage into the macular area. The recent literature is reviewed and the association to midbrain haemangiomas discussed. The ophthalmological differential diagnosis, the prognosis and the present status in treatment is presented.

Entities:  

Mesh:

Year:  1979        PMID: 525291     DOI: 10.1111/j.1755-3768.1979.tb00516.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

1.  Racemose hemangioma type 2: the first case report from the Middle East.

Authors:  Mohammad Reza Eskandari; Babak Rahimi-Ardabili; Alireza Javadzade
Journal:  Int Ophthalmol       Date:  2012-10-04       Impact factor: 2.031

2.  Spontaneous development of retinal ischaemia and rubeosis in eyes with retinal racemose angioma.

Authors:  P A Bloom; A Laidlaw; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

Review 3.  A case report of Wyburn-Mason syndrome and review of the literature.

Authors:  P N Dayani; A A Sadun
Journal:  Neuroradiology       Date:  2007-01-18       Impact factor: 2.995

Review 4.  Retinal vein occlusion in retinal racemose hemangioma: a case report and literature review of ocular complications in this rare retinal vascular disorder.

Authors:  Xue-jiao Qin; Chao Huang; Kun Lai
Journal:  BMC Ophthalmol       Date:  2014-08-21       Impact factor: 2.209

5.  Racemose hemangioma complicated with macular macroaneurysm rupture.

Authors:  Kodai Yamauchi; Yukihiko Suzuki; Takayuki Tanaka-Gonome; Kobu Adachi; Natsuki Maeda; Mitsuru Nakazawa
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.